Xtant Medical Holdings, Inc. XTNT
0.38
0.00
0.00%
as of 25 Sep
- Market cap
- $52.9M
- P/E
- 0.0×
Follow XTNT
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (25.16%) | 3.95% | 10.59% | 3.65% |
+8 more TTM periods Free account |
|
| (12.16%) | 2.10% | 5.29% | 1.71% | ||
ROIC |
(12.43%) | 4.23% | 7.71% | 5.79% | |
Return on Tangible Assets |
(27.60%) | 3.67% | 9.05% | 3.32% | |
Average Days of Receivables |
64.70 | 51.44 | 48.52 | 69.98 | |
Free Cash Flow per Share |
0.00 | 0.06 | 0.07 | 0.04 | |
Free Cash Flow |
(0.46) | 8.00 | 10.40 | 5.48 | |
Capital Expenditures |
(1.03) | (1.15) | (2.15) | (2.35) | |
Piotroski F-Score |
3.00 | 8.00 | 8.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
0.78% | 12.54% | 13.39% | 8.72% | |
Accounts Receivable Turnover |
4.72 | 6.00 | 6.96 | 5.78 | |
Accounts Payable Turnover |
6.65 | 7.28 | 8.44 | 6.67 | |
Inventory Turnover |
1.21 | 1.30 | 1.44 | 1.22 | |
Average Days of Payables |
50.50 | 43.61 | 28.26 | 49.51 | |
Days of Inventory on Hand |
273.15 | 253.49 | 222.46 | 294.04 | |
Tax Rate |
0.21 | (0.53) | (0.29) | (0.22) | |
Research and Development Expense of Revenue |
2.03% | 1.72% | 1.57% | 1.63% | |
Selling, General and Administrative Expense of Revenue |
62.38% | 57.92% | 55.92% | 55.63% | |
Share Based Compensation of Revenue |
2.73% | 2.36% | 2.16% | 2.26% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.05) | 5.01 | 2.52 | 4.47 | |
Depreciation/Fixed assets |
0.73 | 0.80 | 0.84 | 0.45 | |
Capex/Depreciation |
(0.26) | (0.25) | (0.41) | (0.52) | |
Revenue per Share |
0.78 | 0.87 | 0.96 | 0.95 | |
Operating CF per Share |
0.00 | 0.07 | 0.09 | 0.06 | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 | |
Net Profit Margin |
(10.17%) | 1.50% | 3.71% | 1.32% |
Columns are period end dates